{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:35:48Z","timestamp":1788395748747,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013806","name":"Shenyang Pharmaceutical University","doi-asserted-by":"publisher","award":["ZQN202304"],"award-info":[{"award-number":["ZQN202304"]}],"id":[{"id":"10.13039\/501100013806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108862","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T21:50:43Z","timestamp":1754862643000},"page":"108862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design and synthesis of ROCK2-selective inhibitors bearing 6-indazolamino-2-pyrrolidinylpyridine for the treatment of breast cancer metastasis"],"prefix":"10.1016","volume":"164","author":[{"given":"Jiahao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108862_bb0005","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/ijc.34900","article-title":"Unraveling the cross-talk between N6 -methyladenosine modification and non-coding RNAs in breast cancer: mechanisms and clinical implications","volume":"154","author":"Liu","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108862_bb0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108862_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7150\/thno.13896","article-title":"A pH-responsive host-guest Nanosystem loading Succinobucol suppresses lung metastasis of breast Cancer","volume":"6","author":"Dan","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2025.108862_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2024.02.002","article-title":"Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities","volume":"45","author":"Chen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2025.108862_bb0025","unstructured":"Matsui T. Amano M. Yamamoto T. Chihara K. Nakafuku M. Ito M. Nakano T. Okawa K. Iwamatsu A. Kaibuchi K. n.d. Rho-associated kinase, a novel serine\/threonine kinase, as a putative target for the small GTP binding protein Rho."},{"key":"10.1016\/j.bioorg.2025.108862_bb0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr\u2013Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108862_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","article-title":"Breast cancer lung metastasis: molecular biology and therapeutic implications","volume":"19","author":"Jin","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioorg.2025.108862_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10238-016-0444-z","article-title":"Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion","volume":"17","author":"Li","year":"2017","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bioorg.2025.108862_bb0045","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2025.108862_bb0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ki.2010.428","article-title":"Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure","volume":"79","author":"Komers","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bioorg.2025.108862_bb0055","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-09-1541","article-title":"Inhibition of rho-associated kinase signaling prevents breast Cancer metastasis to human bone","volume":"69","author":"Liu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108862_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","article-title":"ROCK inhibition in models of neurodegeneration and its potential for clinical translation","volume":"189","author":"Koch","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.108862_bb0065","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s40265-014-0333-2","article-title":"Ripasudil: First Global Approval","volume":"74","author":"Garnock-Jones","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2025.108862_bb0070","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.bmcl.2016.03.104","article-title":"Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma","volume":"26","author":"Sturdivant","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108862_bb0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1167\/iovs.13-13157","article-title":"AMA0076, a novel, locally acting rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia","volume":"55","author":"Van De Velde","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bioorg.2025.108862_bb0080","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (ROCK) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108862_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108336","article-title":"ROCK inhibitor: focus on recent updates","volume":"34","author":"You","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108862_bb0090","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12203","article-title":"Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis","volume":"5","author":"K\u00fcmper","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.bioorg.2025.108862_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/excr.2000.5046","article-title":"Regulation and functions of rho-associated kinase","volume":"261","author":"Amano","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bioorg.2025.108862_bb0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s40265-021-01593-z","article-title":"Belumosudil: First Approval","volume":"81","author":"Blair","year":"2021","journal-title":"Drugs"},{"issue":"577","key":"10.1016\/j.bioorg.2025.108862_bb0105","first-page":"e1","article-title":"Belumosudil impacts immunosuppression pharmacokinetics in patients with chronic graft-versus-host disease","volume":"29","author":"Gonzalez","year":"2023","journal-title":"Transplant. Cellular Ther."},{"key":"10.1016\/j.bioorg.2025.108862_bb0110","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 inhibition with Belumosudil (KD025) for the treatment of chronic graft-versus-host disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.108862_bb0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioorg.2025.108862_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101576","article-title":"Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.bioorg.2025.108862_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127474","article-title":"Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitors","volume":"30","author":"Hu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108862_bb0130","series-title":"Organic Syntheses","article-title":"5-Nitroindazole: Indazole, 5-nitro","author":"Porter","year":"2003"},{"key":"10.1016\/j.bioorg.2025.108862_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101225","article-title":"Design, synthesis and evaluation of novel pyrido fused piperazine derivatives: in vitro cytotoxicity study over various cancer cell lines","volume":"6","author":"Timaniya","year":"2023","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2025.108862_bb0140","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cmdc.201900112","article-title":"Sulfide analogues of Flupirtine and Retigabine with Nanomolar KV 7.2\/KV 7.3 channel opening activity","volume":"14","author":"Bock","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108862_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.canlet.2015.03.017","article-title":"The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration","volume":"361","author":"Kale","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108862_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12272-019-01153-w","article-title":"Targeting ROCK\/LIMK\/cofilin signaling pathway in cancer","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.108862_bb0155","first-page":"680","article-title":"Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment","volume":"2","author":"Pasha","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.bioorg.2025.108862_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer \u2014 using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:45:13Z","timestamp":1757655913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"alternative-id":["S0045206825007424"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108862","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of ROCK2-selective inhibitors bearing 6-indazolamino-2-pyrrolidinylpyridine for the treatment of breast cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108862"}}